Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q3 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY23
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY23
Cupid Ltd (CUPID) is currently trading at 412.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Cupid Limited manufactures and exports sexual wellness products (male and female condoms, water-based lubricants) and produces rapid IVD diagnostic kits while scaling a consumer FMCG portfolio across personal care, wellness, and fragrance categories; the company serves over 125 countries and holds WHO/UNFPA prequalification and CE/ISO certifications. Q3 FY26 was reported as the company’s best quarter ever with consolidated revenue of ₹104.38 crore and net profit of ₹32.83 crore, reflecting Y-o-Y revenue growth of 101.7% and net profit growth of 196.3%, driven by record order book conversion and rising FMCG contribution. A large multi-year South Africa national program allocation plus other regulated tenders provide about $12.98 million (~₹115 crore) of annual visibility from that single program, materially de‑risking near‑term revenue and underpinning capacity expansion timing decisions. Operational expansion includes a new Palava facility adding meaningful condom capacity and an international manufacturing plan for Saudi Arabia to serve GCC FMCG markets, while diagnostics capacity is being automated to target ~4 lakh IVD kits per day by end‑2026. Strategic capital allocation includes a ₹331.53 crore investment into Style Baazar to secure immediate retail distribution for FMCG SKUs and accelerate projected incremental revenue of ₹150 crore in FY27 and potential ₹500 crore ecosystem revenue within three years.
Over the past 52 weeks, Cupid Ltd has traded between a low of ₹50.00 and a high of ₹527.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Cupid Ltd has a market capitalization of approximately 11,371.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Cupid Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 136.40 and operates in the FMCG sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 11,371.80 Cr, Cupid Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Cupid Ltd operates in the FMCG sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Cupid Ltd is 136.40. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Cupid Ltd. has announced a bonus issue of equity shares in a 4:1 ratio, meaning eligible shareholders will receive four new equity shares for every one existing share they hold.
Cupid Ltd. has announced a bonus issue in the ratio of 4:1, meaning eligible shareholders will receive four new equity shares for every one share they hold.
Cupid Ltd's stock has surged over 580% in the past year due to strong financial performance, including 103% revenue growth, plans to build a manufacturing plant in Saudi Arabia, and a significant reduction in promoter-pledged shares.
The stock surged over 500% in 2025 due to its successful expansion into the FMCG sector, strong financial results with over 100% profit growth, and a significant reduction in promoter-pledged shares, which boosted investor confidence.
Bearish
2
Neutral
6
Bullish
6
Bearish
24
Neutral
6
Bullish
16
Bearish
22
Neutral
0
Bullish
10
Discovery themes featuring this stock
Cupid Limited manufactures and exports sexual wellness products (male and female condoms, water-based lubricants) and produces rapid IVD diagnostic kits while scaling a consumer FMCG portfolio across personal care, wellness, and fragrance categories; the company serves over 125 countries and holds WHO/UNFPA prequalification and CE/ISO certifications.
Q3 FY26 was reported as the company’s best quarter ever with consolidated revenue of ₹104.38 crore and net profit of ₹32.83 crore, reflecting Y-o-Y revenue growth of 101.7% and net profit growth of 196.3%, driven by record order book conversion and rising FMCG contribution.
A large multi-year South Africa national program allocation plus other regulated tenders provide about $12.98 million (~₹115 crore) of annual visibility from that single program, materially de‑risking near‑term revenue and underpinning capacity expansion timing decisions.
Operational expansion includes a new Palava facility adding meaningful condom capacity and an international manufacturing plan for Saudi Arabia to serve GCC FMCG markets, while diagnostics capacity is being automated to target ~4 lakh IVD kits per day by end‑2026.
Strategic capital allocation includes a ₹331.53 crore investment into Style Baazar to secure immediate retail distribution for FMCG SKUs and accelerate projected incremental revenue of ₹150 crore in FY27 and potential ₹500 crore ecosystem revenue within three years.
FMCG
Personal Care - Indian - Medium / Small
11,372 Cr
Low Risk
136.4
156.2
4.1
29.8
527.40
50.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
422.85 | 11,372 Cr | 136.40 | 29.83 | 0.00 | 16.19 | 20.67 | 18.88 | |
325.60 | 495 Cr | — | 0.00 | 0.00 | 59.93 | -12.08 | -24.47 | |
195.55 | 292 Cr | 85.77 | 13.14 | 0.26 | 13.55 | 18.85 | 15.13 | |
116.00 | 287 Cr | 30.93 | 3.18 | 0.00 | 8.72 | 11.88 | 6.94 | |
56.15 | 134 Cr | — | 2.00 | 0.00 | -22.68 | -23.46 | -98.51 | |
116.10 | 111 Cr | — | 3.58 | 0.00 | -3.41 | -3.28 | -13.20 | |
10.48 | 91 Cr | — | 0.51 | 0.00 | -2.92 | -3.49 | -2.57 |
